Literature DB >> 32522014

Circle RNA circABCB10 Modulates PFN2 to Promote Breast Cancer Progression, as Well as Aggravate Radioresistance Through Facilitating Glycolytic Metabolism Via miR-223-3p.

Yue Zhao1, Rui Zhong2, Chaoyue Deng1, Zhenlin Zhou1.   

Abstract

Background: Breast cancer (BC) is a common tumor in women worldwide, and irradiation (IR) resistance is a major obstacle for BC therapy. Circle RNAs (circRNAs) were identified as implicated in the progression of cancer and IR resistance. However, the role of circABCB10 in BC progression and IR resistance is not well defined. Materials and
Methods: The levels of circABCB10, miR-223-3p, and profilin-2 (PFN2) were detected by quantitative real-time polymerase chain reaction. The cell viability and survival rate were monitored by MTT assay. The glucose consumption, lactic acid production, LDH-A activity, and ATP production were evaluated to measure glycolysis. The protein levels of hypoxia inducible factor-1α (HIF-1α), hexokinase 2 (HK2), lactate dehydrogenase A chain (LDH-A), and PFN2 were estimated by Western blot assay. The colony formation rate was tested by colony formation assay. Dual-luciferase reporter assay was constructed to validate the interaction between miR-223-3p and circABCB10 or PFN2. The mice xenograft assay was performed to further verify the effects of circABCB10 on BC progression in vivo.
Results: CircABCB10 and PFN2 were elevated, while miR-223-3p was reduced in BC tissues and cells. CircABCB10 sponged miR-223-3p, and PFN2 was a target of miR-223-3p in BC cells. CircABCB10 silencing inhibited cell proliferation, glycolysis, colony formation, and decreased IR resistance in BC cells by modulating miR-223-3p. Meanwhile, circABCB10 depletion restrained xenograft tumor growth in vivo. Also, miR-223-3p overexpression refrained cell proliferation, glycolysis, and colony formation while improving IR sensitivity in BC cells by regulating PFN2. Besides, circABCB10 knockdown declined PFN2 in BC cells via miR-223-3p. The glycolysis inhibitor 2-deoxy-D-glucose enhanced IR sensitivity in BC cells via circABCB10.
Conclusion: CircABCB10 knockdown contributed to irradiation sensitivity by negatively regulating glycolysis via the miR-223-3p/PFN axis in breast cancer.

Entities:  

Keywords:  PFN2; breast cancer; circABCB10; glycolysis; irradiation resistance; miR-223-3p

Mesh:

Substances:

Year:  2020        PMID: 32522014     DOI: 10.1089/cbr.2019.3389

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  15 in total

1.  Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis.

Authors:  Deyou Kong; Dongxing Shen; Zhikun Liu; Jun Zhang; Jian Zhang; Cuizhi Geng
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-03-03       Impact factor: 2.673

2.  Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p.

Authors:  Penghui Song; Jianjun Wu; Jianbing Chen; Fang Wang; Jingmei Chen; Guanyu Wang
Journal:  Strahlenther Onkol       Date:  2022-10-07       Impact factor: 4.033

Review 3.  Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.

Authors:  Hong Lin; Yuxi Wang; Pinghan Wang; Fangyi Long; Ting Wang
Journal:  Mol Cancer       Date:  2022-07-18       Impact factor: 41.444

4.  The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer.

Authors:  Juan Xu; Xiyi Chen; Yu Sun; Yaqian Shi; Fang Teng; Mingming Lv; Chen Liu; Xuemei Jia
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

Review 5.  Tip of the Iceberg: Roles of CircRNAs in Cancer Glycolysis.

Authors:  Tan Li; Hong-Chun Xian; Li Dai; Ya-Ling Tang; Xin-Hua Liang
Journal:  Onco Targets Ther       Date:  2021-04-07       Impact factor: 4.147

6.  Circular RNA circ_IRAK3 contributes to tumor growth through upregulating KIF2A via adsorbing miR-603 in breast cancer.

Authors:  Fang Wang; Jingruo Li; Lin Li; Zhuo Chen; Nan Wang; Mingzhi Zhu; Hailong Mi; Youyi Xiong; Guangcheng Guo; Yuanting Gu
Journal:  Cancer Cell Int       Date:  2022-02-14       Impact factor: 5.722

7.  miR-223-3p targets FBXW7 to promote epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Yuli Wang; Shuang Shi; Yunshan Wang; Xuhua Zhang; Xiaoyan Liu; Juan Li; Peilong Li; Lutao Du; Chuanxin Wang
Journal:  Thorac Cancer       Date:  2021-12-24       Impact factor: 3.500

Review 8.  Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer.

Authors:  Jinjin Chu; Xianzhu Fang; Zhonghou Sun; Linlin Gai; Wenqing Dai; Haibo Li; Xinyi Yan; Jinke Du; Lili Zhang; Lu Zhao; Donghua Xu; Shushan Yan
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

Review 9.  Circular RNAs as Potential Biomarkers in Breast Cancer.

Authors:  Fatima Domenica Elisa De Palma; Francesco Salvatore; Jonathan G Pol; Guido Kroemer; Maria Chiara Maiuri
Journal:  Biomedicines       Date:  2022-03-21

Review 10.  The biogenesis, function and clinical significance of circular RNAs in breast cancer.

Authors:  Yan Zeng; Yutian Zou; Guanfeng Gao; Shaoquan Zheng; Song Wu; Xiaoming Xie; Hailin Tang
Journal:  Cancer Biol Med       Date:  2021-06-10       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.